Subgroup analysis based on the severity of sarcopenia showed that the methylation levels of CXCL12_22, FGF21_59, and FGF2_30 were also significantly different between patients with moderate sarcopenia and those with severe sarcopenia (Table 1). The gene discussed is FGF2; the disease is sarcopenia.